Market Cap | 516.44M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | - | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -3.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -4.00% |
Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -14.00% | |
Recommedations | - | Quick Ratio | - | Shares Outstanding | 38.24M | 52W Low Chg | 9.00% |
Insider Own | 0.00% | ROA | - | Shares Float | - | Beta | - |
Inst Own | 11.83% | ROE | - | Shares Shorted/Prior | 285.49K/331.49K | Price | 13.61 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 88,622 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 132,514 | Change | -0.73% |
Tekla World Healthcare Fund is a closed-ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector. For its fixed income portion, the fund primarily invests in corporate debt securities. Tekla World Healthcare Fund was formed on June 26, 2015 and is domiciled in the United States.